Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2200159	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	License Renew	2022-06-21					view
JYHZ2200158	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	License Renew	2022-06-21					view
JYHS2200071	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs(5.2)	Import Drug Application	2022-07-06					view
JYHS2200070	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs(5.2)	Import Drug Application	2022-07-06					view
JYHB2400387	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	Supplementary Application	2024-07-25					view
JYHB2300197	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	Supplementary Application	2023-03-28					view
JYHB2200024	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	Supplementary Application	2022-01-14					view
JYHB2200023	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	Supplementary Application	2022-01-14					view
JYHB2101478	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	Supplementary Application	2021-10-21					view
JYHB2101477	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	Supplementary Application	2021-10-21					view
JYHB2101028	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	Supplementary Application	2021-04-10					view
JYHB2101027	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	Supplementary Application	2021-04-10					view
JYHB2002252	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	Supplementary Application	2020-11-09	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	In Review	2020-11-07	view
JYHB2002251	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	Supplementary Application	2020-11-09	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	In Review	2020-11-07	view
JYHB2000988	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs	Supplementary Application	2020-06-25	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-06-29	view
JYHB2000592	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs(5.1)	Supplementary Application	2020-05-15	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-05-26	view
JYHB2000527	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs(5.1)	Supplementary Application	2020-04-29	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-05-12	view
JYHB2000526	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs(5.1)	Supplementary Application	2020-04-29	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-05-12	view
JYHB1900972	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs(5.1)	Supplementary Application	2019-09-25	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2019-11-19	view
JYHB1900971	艾曲泊帕乙醇胺片	eltrombopag olamine	Tablet	Chemical Drugs(5.1)	Supplementary Application	2019-09-07	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2019-11-19	view